Join us today at 11 am EDT/10 am CDT as Xomix CEO Gary Keller and other experts address the changing landscape, lessons learned, and how an individual or small group can seek fresh resources, and find collaborators. To learn more, scroll down for more details; to register, click the link below.
With ongoing upheaval in the world of drug discovery and development, opportunities for participating in new companies and initiatives is growing.
Researchers and business professionals from any vantage point within the industry can have unprecedented access to talent, intellectual property, funding and facilities. Further, the contributions of experienced pharma and biotech leaders are valued in young companies that are hungry for participation in the LIfe Sciences 3.0 community.
In this webinar, experts will address the changing landscape, lessons learned, and how an individual or small group can seek fresh resources, and find collaborators. In addition, discussion of how to vet opportunities from the viewpoints of both the growing company and an individual attracted to the excitement of new opportunities will be addressed.
This session is for those in early stage companies, considering building a new company, or planning to on responsibility for helping young companies grow.